跳至主要内容
临床试验/NCT02297243
NCT02297243已完成早期 1 期

The Sinopsys Lacrimal Stent Indicated for Sinus Irrigation Via Transcaruncular Ethmoid Sinus Access in Patients With Moderate to Severe Chronic Rhinosinusitis With Ethmoid Sinus Involvement

Sinopsys Surgical6 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2015年3月1日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
9
试验地点
6
主要终点
Safety: Incidence and occurrence of anticipated and unanticipated adverse events

研究概览

简要总结

The purpose of this study is to collect preliminary clinical data related to the safety and performance of the Sinopsys Lacrimal Stent.

详细描述

For purposes of this clinical study, the Sinopsys Lacrimal Stent is intended to provide a means of administering saline sinus irrigation via a transcaruncular-ethmoid sinus access in patients with moderate to severe chronic rhinosinusitis with ethmoid involvement. The purpose of the administration of saline irrigation is to reduce the intensity of symptoms of chronic rhinosinusitis in this patient population.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The Investigator has determined that the potential study subject has moderate to severe chronic rhinosinusitis with ethmoid involvement and has followed at least twelve (12) weeks of appropriate medical therapy prior to enrollment
  • Age ≥ 22 years
  • The potential study subject meets the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) criteria for chronic rhinosinusitis 12 weeks or longer of two or more of the following signs and symptoms:
  • Mucopurulent drainage (anterior, posterior, or both)
  • Nasal obstruction (congestion)
  • Facial pain-pressure-fullness, or
  • Decreased sense of smell
  • AND inflammation is documented by one or more of the following findings:
  • Purulent (not clear) mucus or edema in the middle meatus or ethmoid region
  • Polyps in nasal cavity or the middle meatus, and/or
  • Radiographic imaging showing inflammation of the paranasal sinuses
  • SNOT-20 total score ≥ 41
  • CT scan (coronal view) confirms inflammation / involvement of the ethmoid sinuses
  • CT scan (coronal view) confirms depth of olfactory fossa is Keros classification 1 or 2.

排除标准

  • Sinus opacification score of ≤ 8 or ≥ 18 measured using the CT derived Lund -- Mackay scoring system
  • Isolated sinus disease evident on CT scan that would be unlikely to respond to target ethmoid treatment (e.g., isolated sphenoid or frontal disease)
  • Severe polyposis defined as Grade III or Grade IV polyposis using the adapted scale from Meltzer,
  • Prior ocular and/or sinus surgery for CRS
  • CT scan (coronal view) shows depth of olfactory fossa is Keros classification
  • Prior surgical history, physical exam, nasal endoscopy and/or imaging studies suggest significant distortion of the craniofacial anatomy thus prohibiting adequate placement of the SLS
  • Presence of a sinonasal encepholocele as determined by CT scan
  • Presence of active HEENT infection including acute dacryocystitis
  • Febrile illness within 2 weeks and/or active pus from nose
  • Any sign of active ophthalmic disease, infection, or inflammation including the presence of severe ocular surface inflammatory disease or signs and symptoms of "dry eye disease" as determined by physical exam which could be exacerbated by the presence of the device
  • Current use of topical medications for the eye to treat an active ophthalmic disease
  • HbA1c level of ≥ 7.5% at the time of screening, current chemotherapy, or other immune compromised conditions

结局指标

主要结局

Safety: Incidence and occurrence of anticipated and unanticipated adverse events

时间窗: 18 Weeks

Assessment of the incidence and occurrence of anticipated and unanticipated adverse events reported during the 18 weeks of the clinical study.

SNOT - 20

时间窗: 18 Weeks

Chronic Rhinosinusitis symptoms as measured by SNOT-20 scores from baseline to 18 weeks follow-up (1, 4, 8, 12, and 18)

Patency will be confirmed post procedure with passive flow through the SLS lumen by instilling 2-4 drops of sterile saline into the stented medial fornix and observing drainage.

时间窗: 18 Weeks

Patients will be trained for self-administration of saline irrigation prior to the discharge home. Subjects will be instructed how to observe for stent patency and to report problems with flow to the Investigator.

次要结局

  • Lund-MacKay CT Scores(12 Weeks)
  • Lund-Kennedy Nasal Endoscopy Scores(12 Weeks)

研究者

发起方
Sinopsys Surgical
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Sinopsys Lacrimal Stent Indicated for Sinus... | 临床试验